Global Famotidine Market Overview:
Famotidine is a white to pale yellow crystalline compound that is freely soluble in glacial acetic acid, slightly soluble in methanol, very slightly soluble in water, and practically insoluble in ethanol. It is a prescription and over the counter drug used to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed. Famotidine is also used to treat certain stomach and throat problems such as erosive esophagitis, gastroesophageal reflux disease, and Zollinger-Ellison syndrome. It is sold under different brand names such as Pepcid, Act, Dyspep HB, Fluxid, and Acid Controller.
- Increasing Use of Famotidine to Treat Acid Indigestion
- Growing Demand for Famotidine Tablet
- Increasing Use to Treat Zollinger-Ellison Syndrome
- Treatment for Esophagitis
- Famotidine May Cause Some Unwanted Side Effects
- Growing Occurrence of Stomach and Intestine Problems among People
- Increasing Use of Famotidine in Children
- Availability of Alternative Treatments
Some of the key players profiled in the report are Uquifa (Spain), Rakshit Drugs Private Limited (India), Chempro Pharma (India), Gauri Fine Chemicals (India), Darou Pakhsh Pharma Chem Co. (Iran), Pat Impex (India), Wuhan Jayusion Pharmaceutical Technology Co., Ltd (China), Phalanx Labs (India), Teva Pharmaceuticals (United States), Aurobindo Pharma (United States), Alembic Pharmaceuticals Inc (United States), Mylan Laboratories Ltd. (United States), Ercros (Spain) and Jeil Pharmaceutical (South Korea). Considering Market by Route of Administration, the sub-segment i.e. Oral will boost the Famotidine market. Considering Market by Treatment, the sub-segment i.e. Zollinger-Ellison Syndrome will boost the Famotidine market. Considering Market by Dosage, the sub-segment i.e. 0-10 mg will boost the Famotidine market. Considering Market by End User, the sub-segment i.e. Adult will boost the Famotidine market.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Famotidine market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Famotidine market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Famotidine Manufacturer, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End Use Industry.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.